Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

542

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Psoriasis
Interventions
DRUG

Vehicle

DRUG

M518101

Trial Locations (34)

11790

Derm Research Center of New York, Stony Brook

14623

Skin Search of Rochester, Rochester

27262

Dermatology Consulting Services, High Point

28209

PMG Research of Charlotte, Charlotte

28403

Medical Development Center, Wilmington

29464

Coastal Clinical Research Center, Mt. Pleasant

29644

Palmetto Clinical Trial Servises, Fountain Inn

32216

Jacksonville Center for Clinical Research, Jacksonville

33180

The Center for Clinical and Cosmetic Research, Aventura

37215

Tennessee Clinical Research Center, Nashville

40202

Dermatology Specialists Research, Lousville

40217

Derm Research, Louiville

45249

Radiant Research, Cincinnati

46617

South Bend Clinic, South Bend

48088

Grekin Skin Institute, Warren

60077

Northshore University Health System, Skokie

63141

Washington University Dermatology, St Louis

66215

Kansas City Dermatology, Overland Park

70808

Medical Development Center, Baton Rouge

73071

Central Sooner Research, Norman

75246

Menter Dermatology Research Institute, Dallas

78229

Clinical Trials of Texas, San Antonio

78705

Austin Dermatology Associates, Austin

78759

DermResearch, Austin

80220

Horizons Clinical Research Center, Denver

84117

Dermatology Research Center, Salt Lake City

85202

Agave Clinical Research, Mesa

89052

Karl G Heine Dermatology, Henderson

89106

Las Vegas Skin and Cancer Center, Las Vegas

90404

Clinical Science Institute, Santa Monica

91436

T Joseph Raoof, Encino

92108

Medical Center for Clinical Research, San Diego

92123

Therapeutics Clinical Research, San Diego

08520

Center of Central New Jersey, East Windsor

All Listed Sponsors
lead

Maruho North America Inc.

INDUSTRY

NCT01878461 - Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis | Biotech Hunter | Biotech Hunter